Jerome D. Jabbour
2018
In 2018, Jerome D. Jabbour earned a total compensation of $1.3M as Chief Executive Officer at Matinas BioPharma Holdings, a 1% decrease compared to previous year.
Compensation breakdown
| Bonus | $84,000 |
|---|---|
| Option Awards | $804,269 |
| Salary | $366,458 |
| Total | $1,254,727 |
Jabbour received $804.3K in option awards, accounting for 64% of the total pay in 2018.
Jabbour also received $84K in bonus and $366.5K in salary.
Rankings
In 2018, Jerome D. Jabbour's compensation ranked 8,071st out of 14,244 executives tracked by ExecPay. In other words, Jabbour earned more than 43.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,071 out of 14,244 | 43rd |
Division Manufacturing | 3,174 out of 5,759 | 45th |
Major group Chemicals And Allied Products | 1,183 out of 2,122 | 44th |
Industry group Drugs | 993 out of 1,811 | 45th |
Industry Pharmaceutical Preparations | 772 out of 1,385 | 44th |
Source: SEC filing on September 24, 2019.
Jabbour's colleagues
We found four more compensation records of executives who worked with Jerome D. Jabbour at Matinas BioPharma Holdings in 2018.
News
Matinas BioPharma Holdings CEO Jerome Jabbour's 2022 pay falls 55% to $1.7M
September 19, 2023
Matinas BioPharma Holdings CEO Jerome Jabbour's 2021 pay jumps 26% to $3.7M
September 22, 2022
Matinas BioPharma Holdings CEO Jerome Jabbour's 2019 pay rises 6% to $1.3M
October 1, 2020
Matinas BioPharma Holdings CEO Jerome Jabbour's 2018 pay slips 1% to $1.3M
September 24, 2019